Evidence map›Paper›PMID 24979803›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Molecular ties between the cell cycle and differentiation in embryonic stem cells.

Victor C Li, Marc W Kirschner

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Improving iPSC Differentiation Using a Nanodot Platform.ACS applied materials & interfaces · 2024
    Article
  10. Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid-derived suppressor cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Victor C LiDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115.
Marc W KirschnerDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115 marc@hms.harvard.edu.

Funding

BIOCHEMICAL STUDIES OF MITOSISR01GM026875 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KIRSCHNER, MARC WALLACE · 1985 to 2019
$18.2M
BIOCHEMICAL STUDIES OF MITOSISR37GM026875 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI KIRSCHNER, MARC W · 1986 to 1995
–
NIGMS NIH HHS GM26875NIGMS NIH HHS R01 GM026875
6 · The paper itself

Abstract

Attainment of the differentiated state during the final stages of somatic cell differentiation is closely tied to cell cycle progression. Much less is known about the role of the cell cycle at very early stages of embryonic development. Here, we show that molecular pathways involving the cell cycle can be engineered to strongly affect embryonic stem cell differentiation at early stages in vitro. Strategies based on perturbing these pathways can shorten the rate and simplify the lineage path of ES differentiation. These results make it likely that pathways involving cell proliferation intersect at various points with pathways that regulate cell lineages in embryos and demonstrate that this knowledge can be used profitably to guide the path and effectiveness of cell differentiation of pluripotent cells.

Indexed as

AnimalsCell CycleCell DifferentiationChromonesCloning, MolecularDNA PrimersEmbryonic DevelopmentEmbryonic Stem CellsFlavonoidsMAP Kinase Kinase 1MiceMicroarray AnalysisMorpholinesMuscle, SkeletalPhosphoinositide-3 Kinase InhibitorsPlasmids2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneChromonesDNA PrimersFlavonoidsMAP Kinase Kinase 1MorpholinesPhosphoinositide-3 Kinase InhibitorsPurinesRoscovitinedifferentiation modelingguided differentiationproliferation controlsystems biology

Identifiers

PMID24979803
PMCPMC4084474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.